Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries

JAMA

Volumn 304, Issue 3, 2010, Pages 293-302

  Stringer, Elizabeth M ^a   Ekouevi, Didier K ^b   Coetzee, David ^c   Tih, Pius M ^d   Creek, Tracy L ^e   Stinson, Kathryn ^c   Giganti, Mark J ^a   Welty, Thomas K ^d   Chintu, Namwinga ^a   Chi, Benjamin H ^a   Wilfert, Catherine M ^f   Shaffer, Nathan ^g   Dabis, Francois ^h   Stringer, Jeffrey S A ^a  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b Programme PAC CI   (Côte d’Ivoire)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Cameroon Baptist Convention Health Services   (Cameroon)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; ZIDOVUDINE;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CAMEROON; CESAREAN SECTION; CHILD; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MATERNAL AGE; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRENATAL CARE; PRIORITY JOURNAL; SINGLE DRUG DOSE; SOUTH AFRICA; UMBILICAL CORD BLOOD; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; ZAMBIA;

EID: 77954695917     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.990     Document Type: Article

References (30)

1. UNAIDS. Declaration of commitment on HIV/AIDS. Presented at: United Nations General Assembly: Special Session on HIV/AIDS; June 25-27, 2001; New York, New York.
2. Orne-Gliemann JBR, Becquet R, Ekouevi DK, et al. Children and HIV/AIDS. AIDS. 2008;22(7):797-805.
3. UNAIDS. Report on the global HIV/AIDS epidemic. http://www.unaids.org/en/ KnowledgeCentre/HIVData/GlobalReport/2008/2008-Global-report.asp. Accessed April 5, 2010.
4. World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Towards Universal Access. Geneva, Switzerland: World Health Organization; 2006.
5. Global Fund. The Global Fund to fight AIDS, TB, and Malaria. http://www.theglobalfund.org/en/publications/progressreports/. Accessed April 5, 2010.
6. Office of the US Global AIDS Coordinator. Celebrating life. http://www.pepfar.gov/press/fifth-annual-report/index.htm. Accessed April 5, 2010.
7. World Health Organization. Towards universal access. http://www.who.int/ hiv/pub/tuapr-2009-en.pdf. Accessed April 5, 2010.
8. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. Lancet. 1999;354(9181):795-802.
9. Stringer EM, Chi BH, Chintu N, et al. Monitoring effectiveness of programmes to prevent mother-tochild HIV transmission in lower-income countries. Bull World Health Organ. 2008;86(1):57-62.
10. Mate KS, Bennett B, Mphatswe W, et al. Challenges for routine health system data management in a large public programme to prevent mother-tochild HIV transmission in South Africa. PLoS One. 2009;4(5):e5483.
11. Mirochnick M, Clarke DF, Dorenbaum A. Nevirapine: pharmacokinetic considerations in children and pregnant women. Clin Pharmacokinet. 2000;39(4):281-293.
12. Stringer JS, Sinkala M, Goldenberg RL, et al. Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. AIDS. 2004;18(6):939-943. (Pubitemid 38553715)
13. Stringer JS, Sinkala M, Maclean CC, et al. Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS. 2005;19(12):1309-1315. (Pubitemid 41224900)
14. Megazzini KM, Sinkala M, Vermund SH, et al. A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, Zambia. AIDS. 2010;24(3):447-455.
15. Koal T, Burhenne H, Römling R, et al. Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2005;19(21):2995-3001. (Pubitemid 41540724)
16. Laurito TL, Santagada V, Caliendo G, et al. Nevirapine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. J Mass Spectrom. 2002;37(4):434-441.
17. Weerahandi S. Generalized Inference in Repeated Measures: Exact Methods in MANOVA and Mixed Models: Wiley Series in Probability and Statistics. Hoboken, NJ: John Wiley & Sons Inc; 2006.
18. Ekouevi DK, Leroy V, Viho A, et al; ANRS 1201/1202 Ditrame Plus Study Group. Acceptability and uptake of a package to prevent mother-to-child transmission using rapid HIV testing in Abidjan, Côte d'Ivoire. AIDS. 2004;18(4):697-700.
19. Villar J, Ba'aqeel H, Piaggio G, et al; WHO Antenatal Care Trial Research Group.WHOantenatal care randomised trial for the evaluation of a new model of routine antenatal care. Lancet. 2001;357(9268):1551-1564.
20. Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda. Lancet. 2005;366(9492):1182-1188.
21. Plipat T, Naiwatanakul T, Rattanasuporn N, et al. Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003. AIDS. 2007;21(2):145-151.
22. Rollins N, Little K, Mzolo S, et al. Surveillance of mother-to-child transmission prevention programmes at immunization clinics. AIDS. 2007;21(10):1341-1347.
23. Kagaayi J, Dreyfuss ML, Kigozi G, et al. Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda. J Acquir Immune Defic Syndr. 2005;39(1):121-124.
24. Songok EM, Fujiyama Y, Tukei PM, et al. The use of short-course zidovudine to prevent perinatal transmission of human immunodeficiency virus in rural Kenya. Am J Trop Med Hyg. 2003;69(1):8-13.
25. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries. Bull World Health Organ. 2004;82(4):299-307.
26. Painter TM, Diaby KL, Matia DM, et al. Women's reasons for not participating in follow-up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV. BMJ. 2004;329(7465):543.
27. Shapiro RL, Thior I, Gilbert PB, et al. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. AIDS. 2006;20(9):1281-1288.
28. Chi BH, Lee A, Acosta EP, et al. Field performance of a thin-layer chromatography assay for detection of nevirapine in umbilical cord blood. HIV Clin Trials. 2006;7(5):263-269.
29. Cressey TR, Nangola S, Tawon Y, et al. Immunochromatographic strip test for rapid detection of nevirapine in plasma samples from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2007;51(9):3361-3363.
30. World Health Organization. Rapid advice: use of antiretroviral drugs for treating pregnant women and preventing HIV Infection in infants. http://www.who.int/hiv/pub/mtct/rapid-advice-mtct.pdf. Accessed April 5, 2010.